FABINO LIFE SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.73 INR | -4.99% |
|
-4.99% | +4.47% |
| 05-28 | Fabino Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
| 2023 | Fabino Life Sciences Limited Approves Executive Changes | CI |
| Sales 2022 | 42.01M 504K 39.53M | Sales 2023 | 33.61M 403K 31.62M | Capitalization | 63M 755K 59.28M |
|---|---|---|---|---|---|
| Net income 2022 | - 0 0 | Net income 2023 | - 0 0 | EV / Sales 2022 | 1.23 x |
| Net cash position 2022 | 5.42M 65.02K 5.1M | Net Debt 2023 | 1.64M 19.61K 1.54M | EV / Sales 2023 | 1.92 x |
| P/E ratio 2022 |
124
x | P/E ratio 2023 |
600
x | Employees | 10 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | -4.99% | ||
| 1 week | -4.99% | ||
| 1 month | -1.31% | ||
| 3 months | -27.39% | ||
| 6 months | +3.35% | ||
| Current year | +4.47% |
1 week
28.73
28.73
1 month
25.0531.90
Current year
25.0543.84
1 year
25.0543.84
3 years
22.5048.95
5 years
22.5048.95
10 years
22.5048.95
| Managers | Title | Age | Since |
|---|---|---|---|
Pankaj Jain
DFI | Director of Finance/CFO | - | 18/11/21 |
Kanchi Gehlot
CMP | Compliance Officer | - | 01/05/23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 12-25 | |
Gagan Gupta
BRD | Director/Board Member | 36 | 17/10/21 |
| Director/Board Member | 50 | 09/11/21 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/05/24 | 28.73 | -4.99% | 3,000 |
| 23/05/24 | 30.24 | +5.00% | 15,000 |
Delayed Quote Bombay S.E., May 31, 2024 at 11:00 am
More quotes
Fabino Life Sciences Ltd is an India-based pharmaceutical company. The Company offers a range of allopathic and herbal products. Its product categories include allopathic products, Covid-19 products, food supplements, herbal products, multi-vitamin products, and veterinary products. Its allopathic products include AMOXRAG-625, Astrid Syrup, Aurceta AM, Aurifox OZ, Aurirug 200, Aurirug O, Aurnim Plus, Aurstin 250, Ceporag O, Doref M, Dr-DSR, F Plexus A, and Fabpara. Its Covid-19 products include disposable face shield, fabclean hand sanitizer, mask, and personal protective equipment (PPE). Its herbal products include Aurcis-Forte, Aurzyme-Syrup, Ayush Kadha, Coptec-syrup, Cough-Free, DStoren-Syrup, Ecstasy Tilla Oil, Fablactin, Giloy Power, Keepshine Hair Oil, Onion Hair Oil, Pain-Go, Power Malt, Regaliv-ds, Sandy Forte and M-Sharp-Brain-tonic. Its Multi-Vitamin products include Aur D3 Capsules, Coptec Capsules, FABZYM CAPSULE, Oshnine Plus, and Rigovit Softgel Capsules.
Sector
Pharmaceuticals
Calendar
05/11/2024
- Q2 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +4.47% | 762K | |
| +40.73% | 734B | |
| +32.83% | 591B | |
| -6.30% | 350B | |
| +15.15% | 315B | |
| +4.05% | 276B | |
| +15.00% | 238B | |
| +9.78% | 206B | |
| -5.52% | 204B | |
| +6.17% | 161B |
- Stock Market
- Equities
- 543444 Stock
